MALIGNANT MELANOMA IN QUEENSLAND x

Similar documents
Polypoid Melanoma, A Virulent Variant of the Nodular Growth Pattern

Periocular skin cancer

Melanoma. Kaushik Mukherjee MD A. Scott Pearson MD

Malignant Melanoma Early Stage. A guide for patients

Living Beyond Cancer Skin Cancer Detection and Prevention

1. Written information to patient /GP: fax ASAP to GP & offer copy of consultation letter.

MELANOMA. Some people are more likely to get a m Melanoma than others:

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

Clinical Pathological Conference. Malignant Melanoma of the Vulva

Clinical characteristics

Skin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1

They can develop anywhere on the skin and also inside the mouth. They can develop in normal skin or where there is an existing skin mole.

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER VULVAR

Primary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type

Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA)

Skin Cancer - Non-Melanoma

Oral and Maxillofacial Surgery Department

Melanoma: The Basics. What is a melanocyte?

MELANOMA. 4 Fitzroy Square, London W1T 5HQ Tel: Fax: Registered Charity No.

Melanoma in situ. Skin Oncology Team Patient Information Leaflet

What is melanoma? Melanoma dealing with the diagnosis. What is melanoma?

MALIGNANT MELANOMA OF THE HEEL

WHAT DOES THE PATHOLOGY REPORT MEAN?

This is a repository copy of Easily missed? Amelanotic melanoma. White Rose Research Online URL for this paper:

Melanoma Underwriting Presented at 2018 AHOU Conference. Hank George FALU

MOHS MICROGRAPHIC SURGERY: AN OVERVIEW

ALAN K. BUTLER F.R.C.S. Senior Registrar, (1953) described juvenile melanomas. ..:I:;. il:i es. .y p.::.: Le: ::::::;...

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center

Glenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine

Histopathology of Melanoma

Dermatology for the PCP Deanna G. Brown, MD, FAAD Susong Dermatology Consulting Staff at CHI Memorial

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018

المركب النموذج--- سبيتز وحمة = Type Spitz's Nevus, Compound SPITZ NEVUS 1 / 7

CANCER INSIGHT. FOR GPs. Summer 2018 WHAT YOU NEED TO KNOW ABOUT SKIN CANCER VISIT. our Skin Cancer Recognition Toolkit at

Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more

Skin Cancer. Dr Elizabeth Ogden Associate Specialist in Dermatology East and North Herts Dr Elizabeth Ogden

IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY

Skin lesions The Good and the Bad. Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry

D thors have presented data on

Da Costa was the first to coin the term. Marjolin s Ulcer: A Case Report and Literature Review. Case Report. Introduction

Krunal Amin 7/17/2010 Josh Cannon Topics in Biology

Directly Coded Summary Stage Melanoma

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Major Topic. Malignant Melanoma Plastic and Reconstructive Surgery R3 陸尊惠 /VS 吳瑞星

Melanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

Common Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley

Finding Melanoma. Is not easy!

Technicians & Nurses Program

Dermoscopy: Recognizing Top Five Common In- Office Diagnoses

New 2010 CPT Codes (italic font represents a new or revised code/description)

Catholic University of Louvain, St - Luc University Hospital Head and Neck Oncology Programme. Anatomopathology. Pathology 1 Sept.

The prevention, diagnosis, referral and management of melanoma of the skin: concise guidelines

Epithelial Cancer- NMSC & Melanoma

Protocol applies to melanoma of cutaneous surfaces only.

Periocular Malignancies

You Are Going to Cut How Much Skin? Locoregional Surgical Treatment. Justin Rivard MD, MSc, FRCSC September 21, 2018

Large majority caused by sun exposure Often sun exposure before age 20 Persons who burn easily and tan poorly are at greatest risk.

Histopathology: skin pathology

12. Malignant Melanoma of Skin

Diseases of the vulva

Rebecca Vogel, PGY-4 March 5, 2012

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Integumentary System

BACK TO TABLE OF CONTENTS FOCUS ON MELANOMA Oncology Annual Report BAPTIST HEALTH LEXINGTON ONCOLOGY ANNUAL REPORT

I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee

BREAST CANCER SURGERY. Dr. John H. Donohue

SQUAMOUS CELL CARCINOMA

Cutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.

Breast conservation surgery and sentinal node biopsy: Dr R Botha Moderator: Dr E Osman

NAACCR Webinar Series 1

THE pedicled flap, commonly used by the plastic surgeon in the reconstruction

Melanoma. Exceptional healthcare, personally delivered

Kentaro Tanaka, 1 Hiroki Mori, 1 Mutsumi Okazaki, 1 Aya Nishizawa, 2 and Hiroo Yokozeki Introduction. 2. Case Presentation

Nonmelanoma skin cancers

Pathology of the skin. 2nd Department of Pathology, Semmelweis University

Melanoma Case Scenario 1

Multiple Primary Melanoma in a Thai Male: A Case Report

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma

General information about skin cancer

BLADDER CANCER: PATIENT INFORMATION

SARCOMA FOLLOWING X-RAY THERAPY FOR GRAVES' DISEASE

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma

Keppel Street, London WC1E 7HT. In addition, a large proportion of melanomas. been suggested that prolonged exposure to

Glenn D. Goldman, MD. Fletcher Allen Health Care. University of Vermont College of Medicine

Melanocytic Tumors

Sentinel lymph node biopsy

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Melanoma Case Scenario 1

MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

Describe the functions of the vertebrate integumentary system. Discuss the structure of the skin and how it relates to function.

SKIN. 3. How is the skin structured around the finger joints to allow for flexible movement of the fingers?

Assisting diagnosis of melanoma through the noninvasive biopsy of skin lesions

Eyelid basal cell carcinoma Patient information

Guideline for the Management of Vulval Cancer

Melanoma. Understanding your diagnosis cancer.ca

Skin Care in Renal Transplant Patients

Transcription:

MALIGNANT MELANOMA IN QUEENSLAND 35 MALIGNANT MELANOMA IN QUEENSLAND x NEVILLE C. DAVIS, F.R.C.S., FJLA.C.S. Co-ordinator, Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane. Between July 1963 and December 1968, all cases of proven malignant melanoma occurring in Queensland were registered at the Research Unit of the Princess Alexandra Hospital as part of the Queensland Melanoma Project {Davis and Herron, 1966). Duiing 1969, only selected teaching hospital cases were registered. In all, (during the whole period, we have detailed records of 1,514 patients and these constitute the basis of this paper. In all cases, the microscopic diagnoses were reviewed by a panel of pathologists before the case was regarded as proven. EPIDEMIOLOGY Incidence Of the 1,514 patients, 685 (45%) were males and 829 (55%) were females. The average incidence per 100,000 per annum was 15 for males and 19 for females, making an average of 17 new patients per 100,000 per annum (Beardmore, 1972). This incidence is the highest recorded for any country in the world. Contrary to expectations, more patients presented for treatment in the sub-tropical compared with the tropical areas of Queensland. There was a higher incidence of the disease in the coastal regions comparesd with the inland. Age Overall, the most common age group to be affected was the 30 59 years age group. There was a tendency for males to develop melanoma at a slightly older age than females. In general, the older a patient, the greater was his statistical chance of developing a melanoma. Site The most common site in males was the hack of trk, trunk and in females, the lower leg. In contrast to squamous cell carcinoma, there is no particular concentration of melanoma on exposed sites, Mortality The death rate from melanoma per 100,000 of population in Australian States average^) over the years 1961-1970 was; Queensland 4.7, Western Australia 3.2, New South Wales 3.4, South Australia 2.6, and Victoria 2,5. This rising gradient in mortality increasing as the Equator is approached, has existed within Australia every year since 1950. It is worth noting that the total number of deaths in proportion to population is increasing each year, This may reflect an increasing incidence of the disease. 1 Delivered at the XIII Biennial Congress of the Australian Physiotherapy Association, Brisbane, August, 1973. CLINICAL DIAGNOSIS A melanoma should be suspected on the history and clinical appearance, anid the diagnosis should be confirmed by microscopic examination. History A history of recent change, particularly over a period of weeks or months in a pre-existing or newly developed mole is of vital importance to the diagnosis. Malignant melanoma should be suspected if any one of the following changes has occurred: <i) Change in size: The lesion has spread out to cover a larger area, (ii) Change in elevation: A lesion previously flat has become elevated or a nodule has developed within the tumour, (iii) Change in colour: Usually a brown mole has become darker or black. The change in pigmentation may not be uniform leading to a variety of colours, including all shades of brown, blue, grey, black and pink. Sometimes a pink, or amelanotic, tumour develops in a dark mole and, to an inexperienced observer, this may look like a granuloma or an infected lesion. A most characteristic change is the development of pale areas of depigmentation within the pigmented tumour. Under the microscope these are seen to be areas of local tumour regression. Sometimes an intensity of pigmentation develops at the periphery referred to by some writers as a "halo" or "flare", terms best avoided as they mean different things to different observers, (iv) Change in surface characteristics: The surface which was previously smooth has become rough and scaly. Sometimes the melanoma is brought to the attention of the patient because he finds a serous discharge or blood on his clothes. Bleeding from a mole after trivial trauma must make one suspect malignancy. The bleeding is usually only relatively minor in contrast with the more profuse haemorrhage which may occur from a haemangioma or pyogenic granuloma, (v) Change in sit? roundings: In more advanced cases, pigmented or amelanotic tumours may develop in the immediate vicinity of the original melanoma, (vi) Change in sensation: A mole may begin to itch or tingle* Appearance An experienced observer should be able to diagnose correctly a malignant melanoma in a majority of cases by its clinical appearance taken in conjunction with the history (Davis et alii, 1966). The tumour should be examined carefully in a good light with a magnifying lens, A particular note should be made of its size, colour, surface and outline. Most melanomas are more than 0,5 cms in diameter. As Aust.J.Physiother., XX, 1, March, 1974

36 THE AUSTRALIAN JOURNAL OF PHYSIOTHERAPY previously noted, close inspection of a melanoma may reveal a variety of colour combinations, varying from brown, black, grey, blue, pink anld even white. A translucent dark grey colour or pale areas of depigmentation in an overall black mole is particularly suggestive of melanoma (Figure 1). FIGURE 2 Malignant Melanoma nodular o> polypoid in type. FIGURE 1 Malignant Melanoma showing typical area of depigmentation. The surface of the tumour is usually raised slightly above the surrounding skin and is easily palpable. In some melanomas, discrete, rounded tumour nodules stand out clearly from the rest of the neoplasm. These nodules may be black, grey or pink. Clark et alii (1969) have 'described a particular type of melanoma nodular melanoma which presents as a blue-black polypoidal or pedunculated tumour with no flat component (Figure 2). Some melanomas have a scaly surface with a crusted and opaque appearance. The surface may be ulcerated, which accounts for the serous or bloodstained discharge* The outline of a melanoma is usually irregular with indentations anld protrusions. A red rim of inflammation can sometimes be seen surrounding a melanoma. A special variety of melanoma, that arising from a Hutchinson's melanotic freckle or lentigo maligna, occurs most commonly on the face of elderly persons (Figure 3). It is characterised by its slow growth, flat surface, and irregular outline. It is not usual to see coarse hairs growing from an invasive melanoma, except in melanomas of the scalp, LOCAL SURGICAL THEATMENT If the diagnosis of malignant melanoma lias been made clinically with confidence, or by frozen or paraffin section, a decision must be made on the extent of surgery necessary. AustJ.Physiotker., XX, 1, March, 1974 Malignant Melanoma arising from a Hutchinson's Melanotic Freckle (Lentigo Maligna). There is much variation in the width an(d extent of surgery advised in the surgical literature. Southwick (1964) advises a margin of at least 2 cms of

MALIGNANT MELANOMA IN QUEENSLAND 37 grossly normal skin while Wilkinson and Paletta (1969) suggest 3 4 cms. Petersen et alii (1962) advocate a clear margin of at least 5 cms and Hiles et alii (1969) 10-15 cms in all directions if the lesion is on the trunk. For lesions in particular sites such as subungual melanoma, amputation of a digit or extremity has been advocated (Attie aiud Khafif, 1961). Olsen (1964) is in favour of preserving the deep fascia while Cade (1961) recommends a threedimensional excision including the deep fascia. Others, such as Lund and Ihnen (1955), McCune and Letterman (1955), Pack et alii (1945) go further an d advocate the inclusion of elective regional node dissection routinely at the time of excision of the primary tumour. Malignant melanoma has a bad reputation and, for many years, the diagnosis was regarded as a sentence of death. Nowadays, the outlook is not as black as it was once painted (McLeod et alii, 1971). The first point to be majde is that not all patients with malignant melanoma should undergo the same treatment. Account must be taken of the clinical and pathological features of the tumour, its anatomical site, as well as the age and sex of the patient. Factors which are known to influence the prognosis should be taken into consideration before deciding on the width of excision. If the prognosis in certain circumstances is known to be very good, it is likely that radical surgery to the primary tumour is not necessary. PftocNosnc FACTORS History We have no statistical evidence but we suspect that a history of rapid change in a melanoma, e.g., over a period of weeks, is associated with a worse prognosis than a history of minimal change over a period of years. There is evidence that inadequate excision or incision (Tod, 1944) and treatment by cautery or diathermy (Molesworth, 1944) is followed by a bad prognosis. Site Patients with melanomas on the back have the worst prognosis of all (Beardmore et alii, 1969). Patients with melanomas of the scalp, vulva and the sole of the foot have done poorly in Queensland. Our retrospective study (McLeod et alii, 1968) showed that patients with melanomas on the forearm had a lower (7.3 per cent) 10 year mortality than those with melanomas on the upper arm (40 per cent); those with melanomas on leg a lower 10-year mortality (32 per cent) than those with melanomas on the thigh (50 per cent). Size If melanomas arising from a Hutchinson's melanotic freckle are excluded, lesions over 2 cm in size have a worse prognosis than smaller lesions (Beardmore et alii, 1969). Shape There is abundant evidence both from Queensland and abroad that pedunculated and nodular melanomas have a worse prognosis than flat lesions (Beardmore et alii, 1969; Clark et alii, 1969). Ulceration Ulceration, even if evident only on microscopic examination, is associated with a poor prognosis (Beardmore et alii, 1969). Microscopic Findings If the melanoma has arisen from a Hutchinson's melanotic freckle (lentigo maligna) the prognosis is usually goodi (Clark et alii, 1969), probably because it is slow to invade deeply. The depth of invasion of the tumour cells is probably the most important factor in prognosis. If the tumour cells are confined to the epidermis (stage I melanoma or melanoma in situ) or invade only to the papillary layer of the dermis (stage 2 or superficial malignant melanoma) the outlook is excellent (McLeod et alii, 1971). In contrast, melanomas invading to the reticular layer of the dermis or beyond (stages 3 anfdi 4), particularly if the dermal lymphatics are involved^ have a worse prognosis (McLeod et alii, 1971, Clark et alii, 1969). Sex All recent surveys including our own (Beardmore et alu, 1969) show a distinctly better prognosis for females than for males. This is particularly true for women of premenopausal age (McLeod et alii, 1971). With all the above theoretical considerations, we are faced with the practical problem of how widely and deeply to excise a melanoma in an individual patient, A good standard margin for initial consideration is 5 cms. This should be reduced or increased according to individual circumstances. Probably the most important of the factors to be considered are the depth of invasion of the tumour cells, the sex of the patient, the histogenesis of the tumour (Clark et alii, 1969), and its anatomical site. Where the prognosis is thought to be good, the margin may be reduced for example, a melanoma arising in a Hutchinson's melanotic freckle on the face of an elderly female requires excision with a margin of 1 cm or even less if anatomical considerations require it. Where the prognosis is known to be bad for example, on the back of a male, the wifdth of excision may be increased but it is not proven that this will affect the result. It all comes back to surgical judgment a 2 cm margin may be adequate for a slowly growing superficial melanoma on the leg of a female and yet grossly inadequate for a large ulcerating raised lesion on the chest near the axilla of a male which may be better treated by excision with a margin of more than 7-10 cms towards the axilla and an incontinuity lymph node dissection. The defect following excision should be covered by a split skin graft in preference to a flap except in special circumstances. The main reason for this recommendation is that local recurrence is much easier to detect in relation to a split skin graft than under a local flap. Aust.].Physiother., XX, 1, March, 1974

38 THE AUSTRALIAN JOURNAL OF PHYSIOTHERAPY Olsen (1964) presented results, following excision of melanomas, which were better when the deep fascia was preserved than when it was removed. We have not been able to confirm this finding. Probably the issue is not of vital importance. We usually include the deep fascia when present in our excision to reduce the risk of cutting too close to the deep surface of the tumour. One point should be emphasised the first treatment of a melanoma is the most vital as it carries the greatest possibility of cure. Regional Nodes Nodes that are clinically involved or about which there is suspicion should be excised. However, there is no place for the routine removal of apparently normal lymph nodes draining a primary melanoma. Each patient should be considered as a separate therapeutic problem, taking into account the biological activity of the tumour, the resistance of the host and the follow-up facilities (Davis and McLeod, 1971). In general, we advocate regular clinical evaluation and avoid elective dissection when (a) we are not certain which nodes to remove, (b) the tumour is at a distance from the nodes or (c) when there is statistical evmence to suggest a good prognosis. The precise indications of elective lymphadenectomy are not easy to define but it seems reasonable to advocate it when a deeply invasive melanoma overlies or is immediately adjacent to the regional nodes. In patients whose prognosis is likely to be bad, it may not matter much whether elective lymphadenectomy is done or a waiting policy adopted, provided the follow-up is good. But many surgeons would advocate elective operation for patients with a poor prognosis even though some will die of bloodborne metastases. Where possible, the operation should be performed synchronous with excision of the primary tumour, an,d all tissue between the primary and nodes should be removed in continuity with radical dissection of the nodes. ROLE OF THE PHYSIOTHERAPIST The physiotherapist plays an important part in the post-operative care of the patient who has had skin grafting performed. The joints near the graft are kept mobile with active movements. When the surgeon indicatesj the patient is mobilised. ReeSducation in walking is necessary when the melanoma and graft are in the lower limbs. Lymphoedema especially of the lower limbs is a relatively common complication of radical block dissection of the nodes. It may follow delayed healing of the groin wound and occasionally reaches massive proportions. Suction drainage of the wounds has helped to reduce the magnitude of this problem. Exercises in elevation, elevation of the limb itself, alternating pressure sleeve application and supporting stockings help to reduce the oedema. Many patients require support of their lower limbs for six months after operation. AustJ.Physiother., XX, 1, March, 1974 RESULTS OF TREATMENT The prognosis for females was significantly better than that for males (McLeod, 1972). Life table studies have shown that the cumulative proportions surviving to the end of five years were 82.6% for females and 64.7% for males. Premenopausal females have a very goo)d prognosis a death rate due to melanoma of 5.5% at five years. SUMMARY AND CONCLUSIONS Malignant melanoma is more common in Queensland than anywhere else in the world. Females develop the tumour more frequently than males but have a better prognosis. A confident clinical diagnosis is possible in the majority of cases by close inspection of the tumour, particularly if there is a history of change in its size, elevation, colour or surface characteristics. The extent of local surgery necessary is controversial and depends on the clinical and pathological features of the tumour, its anatomical situation and the age and sex of the patient. The regional nodes should be excised if they are clinically involved or suspected to be so, If the draining nodes are apparently normal, observation is recommended in preference to elective dissection, except in special circumstances. Tire physiotherapist has an important role in rehabilitating patients who have had skin grafts and block dissection. The results of surgical treatment are goold better than in many other malignancies. ACKNOWLEDGEMENTS The Queensland Melanoma Project is supported by the Queensland Cancer Fund. The Project depends on team work, and, without the co-operation of my colleagues Drs. G. R. C. McLeod, G. L. Beardmore, J. H. Little and R. L. Quinn and of the medical profession in Queensland, this report would not be possible. I thank Miss M. Peel and Miss H. Mellor for constructive suggestions during the preparation of this paper, REFERENCES ATTIE, J. N. and KHAFIF, R, A. (1964). Melanotic Tumours, Thomas, Springfield, Illinois. BEARDMORE, G. L., DAVIS, N. C., MCLEOD, R. et alii (1969). "Malignant Melanoma in Queensland: A Stuldy of 219 Deaths". AustJJ)erm. 9 10: 158. BEARDMORE, G. L. (1972). "The Epidemiology of Malignant Melanoma in Australia" in "Melanoma and Skin Cancer". Proceedings of International Cancer Conference, Sydney, 1972, V. C. N. Blight, Govt. Printer. CADE, S. (1961). "Malignant Melanoma." Ann.Roy. CollSurg., Eng 28: 331. CLARK, W. H., Jr., FROM. L., BERNARDINO, E. A. and MIHM, M. C. (1969). "The Histogenesis and Biologic Behaviour of Primary Human Malignant Melanomas of the Skin." Cancer Res., 29: 705. DAVIS, N. C, and HERRON, J. J. (1966). "Queensland Melanoma Project: Organisation and a Plea for Comparable Surveys." MedJ.Aust., 1: 643.

MALIGNANT MELANOMA IN QUEENSLAND 39 DAVIS, N. C, HERRON, J. JL, and MCLEOD, G. R. C. (1966). "The Macroscopic Appearance of Malignant Melanoma of the Skin." MedJ.Au$L, 2: 883. DAVISI, N. C, and MCLEOD, G. R. (1971). "Elective Lymph Node Dissection for Melanoma." BritJ. Surg., 58: 820. HILES, R, W., BODEKHAM, D. C, LLOYD, 0. C. et alii (1969). "Malignant Melanoma of the Skin" in Recent Advances in Surgery, 7th Edition, edited by Taylor S. Churchill, London. LUND, R. H and IHNEN, M. (1955), "Malignant Melanoma Clinical and Pathological Analysis of 93 Cases. Is Prophylactic Lymph Node Dissection Indicated?" Surgery, 38: 652. MCCUNE, W. S. f and LETTERMAN, G. S. (1955). "Malignant Melanoma: Ten Year Results following Excision and Regional Gland Resection." Ann. Surg., 141: 901. MCLEOD, G, R., BEABDMORE, G. L., LITTLE, J. H. et alii (1971). "Results of Treatment of 361 Patients with Malignant Melanoma in Queensland." Med. JAust., 1: 1211. MCLEOD, R., DAVIS, N. C, HERRON!, J. J. et alii (1968). "A Retrospective Survey of 498 Patients with Malignant Melanoma." Surg., Gynec. Obstet,, 126: 99. MCLEOD, G. R. C. (1972). "Factors Influencing Prognosis in Malignant Melanoma" in "Melanoma and Skin Cancer." Proceedings of International Cancer Conference, Sydney, 1972. V. C. N. Blight, Govt. Printer. MILTON, G. W., and JELIHOVSKY, T. (1962). "Frozen Section Examination in the Diagnosis of Cutaneous Malignant Melanoma (Melanohlastoma)." MedJ. Aust., 2: 503. MOLESWORTH, E. H. (1944). An Introduction to Dermatology. Churchill, London, 484. OLSEN, G. (1964). "Removal of Fascia Cause of More Frequent Metastases of Malignant Melanomas of the Skin to Regional Lymph Nodes?" Cancer, 17: 1159. PACK, G. T., SCHARNAGEL, I., and MORFIT*, M. (1945). "The Principle of Excision and Dissection in Continuity for Primary and Metastatic Melanoma of the Skin." Surgery, 17: 849. PETERSEN, N. C, BODENHAM, D. C, and LLOYD, 0. C, (1962). "Malignant Melanomas of the Skin." BriU.Plastic Surg., 15: 49, 97. SOUTHWICK, H. W, (1964). "Malignant Melanoma - How Much Surgery." MinnMed., 47: 1333. TOD, M. C. (1964). "Tragedy of Malignant Melanoma." Lancet, 2: 532. WILLIS, R. A. (1960). Pathology of Tumours, 3rd Edition. Butterworth, London. WILKINSON, T. S. anld PALETTA, F. X. (1969). "Malignant Melanoma: Current Concepts." Amer. Surg., 35: 301. Au$tJ.Physiother., XX, 1, March, 1974